The subscription/printing for/of the Journal of Medical Research and Innovation shall be managed/handled by AkiNik Publications, New Delhi, India. The subscription charges will be ₹3000 or $120 per year.
All subscriptions are payable in advance and all rates include postage and taxes. Issues will be sent on receipt of
payment. Subscriptions are entered on an annual basis and are subject to renewal in subsequent years.
Please fill this form: https://www.akinik.com/SubscriptionForm.pdf and send this form with payment to (By speed post/courier only):
Subscription Manager, AkiNik Publications
H. No. 169, Pocket C-11, Sector-3, Rohini, New Delhi-110085, India.
Ph.:+91-9711224068; E-mail: firstname.lastname@example.org; web.: https://www.akinik.com
A new journal dedicated to Orthopedics and Musculoskeletal disorders launched by Medkrux. To know more, visit www.jomr.net
Kindly note, that JMRI shall not accept case reports from now onwards. If you would like to submit a case report, kindly submit in our sister journal: Journal of Case Reports and Series.
The current average peer reviewing time is appx. 7 weeks. However, the average time for the first decision made is appx. 5 weeks.
There is a possibility that the time for your paper may vary, if we do not find relevant reviewers for your paper. However, you can help us with this regard by providing the names of two reviewers who can potentially review your paper (Cannot be from your institution or who have worked with you in last one year).
Please bear with us, as we try our best to find reviewers in time. But, we promise to provide a fair and timely experience to every one of you.
We are pleased to say that JMRI shall now display CrossMark on each article published henceforth (may be even all those are already published so far). This will enable us to provide current information of each published paper. Read more about crossmark at https://www.crossref.org/services/crossmark/
After getting many request to start a research group, we have finally started one for all medicos. To read more kindly visit: http://medkrux.com/research-group.
JMRI has now been indexed in Index Copernicus with Index Copernicus Value (ICV) as 79.03. The ICV is of 2017 which also was our first year of publication. Congrats to the JMRI team.
Link to the JMRI page on Index Copernicus: https://journals.indexcopernicus.com/search/details?id=47018&lang=en
The water level in flood-hit Kerala has started to decline, but rebuilding Kerala could take years. As the rains ease, the focus will be on aiding those whose houses and livelihoods were destroyed, a scale of rebuilding which will require billions of dollars.JMRI has donated its share for the relief. For those who want to contribute towards the cause but don’t know how, here’s a link: https://donation.cmdrf.kerala.gov.in/#donation Regards, Dr. Varshil Mehta Editor in Chief, JMRI
Want to submit an article in JMRI? Make sure you have read these important points.
1) Plagiarism: Whether the paper is plagiarised? JMRI shall not allow plagiarism at any cost and from today onwards, we will be banning the corresponding author, in case his/her paper is found to be plagiarised. The authors can self check the plagiarism by using iAuthenticate or Turnitin or Plagiarism checker X.
2) Ethics & Consent: The study should have been approved by the ethical committee of the institution and the patients consent should have been taken prior to submission of the paper. We may ask for the proof during the review. Also, the statements regarding Ethics & Consent should be mentioned in the text, without which we shall not proceed further.
3) Reference format: JMRI only accepts Vancouver style of references. Please make sure you have formated the references as per JMRI's custom style of vancouver. DOI, PubMed ID and direct links should also be added at the end of each reference. More details shall be found out in the Author's guidelines.
4) Conflict of Interest: A statement regarding conflicts for each author should be mentioned in the text.
If there is any mistake with regards to the above points, JMRI will not accept the article. Till date, we were lenient about such mistakes, however, we would not accept any such errors from now onwards due to time constraints.
Since, JMRI has been following Committee on Publication Ethics (COPE) guidelines; it is our request to the authors, peer reviewers and editors of the journal to have a look on the guidelines before submitting, reviewing and editing the papers respectively. Read more on https://publicationethics.org/resources
JMRI Open will be an open access journal and will complement JMRI. Both the journals will run independent of each other; however, a transfer of articles shall be permitted between both the journals. For 2018, all articles shall be published for free. The JMRI Open shall run under guidance of Editor in Chief Dr. Shakti Goel and Managing Editor Dr. Varshil Mehta. It will cover all aspects of medical specialties. Link to the journal: http://open.jmri.org.in
You may download it from https://play.google.com/store/apps/details?id=com.app.jmrikqbp
We have 4 options: 1) Non-open access (Subscription based): NIL/0 USD, 2) Open Access: 99 USD, 3) Individual Fellowship: 199 USD (Publish unlimited open access articles in one year) and 4) Institutional Membership: 999 USD (All authors from the institution can publish open access articles for free).
This model of APC will enable every one to publish articles. The authors can decide about the same and let us know, only after the article is accepted which will help in removing the bias.
From second volume, second issue: All articles published in JMRI will either be published for free (subscription based-only subscribers will be able to access the full article for free and non-subscriber will be able to buy the article for 5 USD) or for with a fees of 100 USD (Open Access- Any one can get access to the full article without any cost). Authors may select any of the above option after the acceptance of the article.
BioMedPress (http://www.biomedpress.org/) has accepted to sponsor JMRI for CrossRef DOI and Cross Mark for the year 2017-2018 with no fees. We are really grateful to Dr. Phuc Van Pham for helping us out. With that said, BioMedPress becomes JMRI's official sponsorer and publisher for the year 2017-18. We wish BioMedPress all the success in future and once again thank them for sponsoring us. JMRI team.
The Journal of Medical Research and Innovation has been awarded as the Best Medical Journal (New) of the year 2017 by Indian Health Professional Awards (Healthcare Oscars of India). Dr. Varshil Mehta (Editor in Chief) will be collecting the award on the team‘s behalf from Mr. Milkha Singh in the awards ceremony event which will be held on 23rd December, 2017 in New Delhi.
We are pleased to announce the beginning of our new section "An Interview with the corresponding author". From today onwards, each article will have a "Interview" section, which will have the interview in writing with the corresponding authors. This is happening for the first time in the world. Before we used to have podcast, but not written interviews for every article published.
JMRI now invites you all to partner with us and publish articles from your hospital or medical college for free and in a stipulated time of 3 weeks (if accepted post peer reviewed). Contact us on email@example.com and start showcasing your research today.
Publons will give an opportunity to all of our reviewers to maintain a reviewer's profile and TrendMD will help us to spread our articles across the websites of the leading publishers like BMJ, Elsevier, Nature etc. For more info, kindly visit their respective websites (Publons and TrendMD).
As per the policy of JMRI, we would re-shuffle the Editorial Board by adding new members and terminating the contracts of old members based on perfomance from 1st June, 2017. Re-Shuffling is done routinely every 6 months for the benefit of the academic world.
The EB is not only for name sake and we are only keen to keep the active members. Hence, we are giving one month time for the members to email us and show their support for JMRI.
The termination shall be made otherwise without any further communication. The editors can however, ask for certificate for being a part of EB of JMRI. Hoping to see every one's support.
Dr. Varshil Mehta,
Editor in Chief,
Journal of Medical Research and Innovation.
JMRI launches Best Article Award 2017. One best each Original Article, Review Article and Case Report will be selected based on readership and citations received. The corresponding author of these articles will be honoured with a certificate and Indian Rupees 1,500.
Editor in Chief,
Dr. Varshil Mehta